| abstract |
The invention relates to benzamide compounds substituted by trifluoro-methyl of Formula (I), to pharmaceutical products comprising these compounds, to their use as or for the manufacture of pharmaceutical products, in particular as inhibitors of protein kinases and / or the treatment of a condition, disorder, or disease state mediated by the activity of a protein kinase, and / or a proliferative disease, to treatment methods comprising administering the compounds, especially therapeutic and prophylactic treatment, to methods for the manufacture of the compounds, already novel intermediaries and partial steps for their synthesis. |